The DOI matches its Crossref record; 396 of the 396 references it cites were found in a registry or an index.
Intestinal permeation enhancers for oral peptide delivery
Open accessAbstract
Intestinal permeation enhancers (PEs) are one of the most widely tested strategies to improve oral delivery of therapeutic peptides. This article assesses the intestinal permeation enhancement action of over 250 PEs that have been tested in intestinal delivery models. In depth analysis of pre-clinical data is presented for PEs as components of proprietary delivery systems that have progressed to clinical trials. Given the importance of co-presentation of sufficiently high concentrations of PE and peptide at the small intestinal epithelium, there is an emphasis on studies where PEs have been formulated with poorly permeable molecules in solid dosage forms and lipoidal dispersions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Peptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
Solubilization of membranes by detergents
Helenius, A., & Simons, K. (1975) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(75)90016-7 · Cited by 2,932
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Pouton, C. W. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.016 · Cited by 1,293
Pouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,230
The basics and underlying mechanisms of mucoadhesion
SMART, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.001 · Cited by 1,167
Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide
Lau, J., Bloch, P., Schäffer, L., Pettersson, I., Spetzler, J., Kofoed, J., Madsen, K., Knudsen, L. B., McGuire, J., Steensgaard, D. B., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00726 · Cited by 1,105
Fasano, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2008 · Cited by 1,003
Ma, T. Y., Iwamoto, G. K., Hoa, N. T., Akotia, V., Pedram, A., Boivin, M. A., & Said, H. M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00173.2003 · Cited by 909
Proinflammatory Cytokines Disrupt Epithelial Barrier Function by Apoptosis-Independent Mechanisms
Bruewer, M., Luegering, A., Kucharzik, T., Parkos, C. A., Madara, J. L., Hopkins, A. M., & Nusrat, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6164 · Cited by 902
Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics
Heitz, F., Morris, M. C., & Divita, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00057.x · Cited by 867
Transit of pharmaceutical dosage forms through the small intestine.
Davis, S. S., Hardy, J. G., & Fara, J. W. (1986) · Gut · doi:10.1136/gut.27.8.886 · Cited by 853
Tight junctions and the molecular basis for regulation of paracellular permeability
Anderson, J. M., & Van Itallie, C. M. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.269.4.g467 · Cited by 843
MOLECULAR AND FUNCTIONAL ANALYSIS OF CADHERIN-BASED ADHERENS JUNCTIONS
Yap, A. S., Brieher, W. M., & Gumbiner, B. M. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.119 · Cited by 805
Crosstalk of tight junction components with signaling pathways
González-Mariscal, L., Tapia, R., & Chamorro, D. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.018 · Cited by 759
Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.
Madara, J. L., & Stafford, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113938 · Cited by 754
Oral drug absorption enhancement by chitosan and its derivatives
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00231-9 · Cited by 689
Cell penetration by transportan
Pooga, M., Hällbrink, M., Zorko, M., & Langel, U. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.67 · Cited by 679
Solubilization of phospholipids by detergents structural and kinetic aspects
Lichtenberg, D., Robson, R. J., & Dennis, E. A. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90004-7 · Cited by 670
McConnell, E. L., Basit, A. W., & Murdan, S. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.1.0008 · Cited by 654
Structure, dynamics and transport properties of microemulsions
Moulik, S. P., & Paul, B. K. (1998) · Advances in Colloid and Interface Science · doi:10.1016/s0001-8686(98)00063-3 · Cited by 623
Clostridium perfringens Enterotoxin Fragment Removes Specific Claudins from Tight Junction Strands
Sonoda, N., Furuse, M., Sasaki, H., Yonemura, S., Katahira, J., Horiguchi, Y., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.195 · Cited by 610
IL-1β Causes an Increase in Intestinal Epithelial Tight Junction Permeability
Al-Sadi, R. M., & Ma, T. Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4641 · Cited by 601
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging
SCHILLER, C., FRÖHLICH, C. ‐., GIESSMANN, T., SIEGMUND, W., MÖNNIKES, H., HOSTEN, N., & WEITSCHIES, W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02683.x · Cited by 596
Restoration of Barrier Function in Injured Intestinal Mucosa
Blikslager, A. T., Moeser, A. J., Gookin, J. L., Jones, S. L., & Odle, J. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2006 · Cited by 574
The safety of chitosan as a pharmaceutical excipient
Baldrick, P. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2009.09.015 · Cited by 569
Bile acids: Chemistry, physiology, and pathophysiology
Monte, M. J., Marin, J. J., Antelo, A., & Vazquez-Tato, J. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.804 · Cited by 569
Wong, V., & Gumbiner, B. M. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.2.399 · Cited by 539
A practical note on the use of cytotoxicity assays
Weyermann, J., Lochmann, D., & Zimmer, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.09.018 · Cited by 525
Lipid Rafts, Detergent-Resistant Membranes, and Raft Targeting Signals
Brown, D. A. (2006) · Physiology · doi:10.1152/physiol.00032.2006 · Cited by 463
Eudragit®: a technology evaluation
Thakral, S., Thakral, N. K., & Majumdar, D. K. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.736962 · Cited by 458
Ma, T. Y., Boivin, M. A., Ye, D., Pedram, A., & Said, H. M. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00412.2004 · Cited by 452
Madara, J. L., Barenberg, D., & Carlson, S. (1986) · The Journal of cell biology · doi:10.1083/jcb.102.6.2125 · Cited by 438
Chitosan and its derivatives as intestinal absorption enhancers
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00180-6 · Cited by 430
Microemulsions: An Overview and Pharmaceutical Applications
Tenjarla, S. (1999) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v16.i5.20 · Cited by 428
Butler, J. M., & Dressman, J. B. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22217 · Cited by 427
Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia.
Nusrat, A., Giry, M., Turner, J. R., Colgan, S. P., Parkos, C. A., Carnes, D., Lemichez, E., Boquet, P., & Madara, J. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10629 · Cited by 418
Mechanism of IL-1β-Induced Increase in Intestinal Epithelial Tight Junction Permeability
Al-Sadi, R., Ye, D., Dokladny, K., & Ma, T. Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5653 · Cited by 417
Borchard, G., Lueβen, H. L., de Boer, A. G., Verhoef, J. C., Lehr, C.-M., & Junginger, H. E. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00146-8 · Cited by 393
Cui, F., Shi, K., Zhang, L., Tao, A., & Kawashima, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.013 · Cited by 391
Hecht, G., Pothoulakis, C., LaMont, J. T., & Madara, J. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113760 · Cited by 390
Approaches for the development of solid and semi-solid lipid-based formulations
Jannin, V., Musakhanian, J., & Marchaud, D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.006 · Cited by 388
Schipper, N. G. M., Vårum, K. M., & Artursson, P. (1996) · Pharmaceutical Research · doi:10.1023/a:1016444808000 · Cited by 384
Sphingomyelins in bilayers and biological membranes
Barenholz, Y., & Thompson, T. E. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90572-6 · Cited by 368
Emerging Trends in Oral Delivery of Peptide and Protein Drugs
Mahato, R. I., Narang, A. S., Thoma, L., & Miller, D. D. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.30 · Cited by 352
Nusrat, A., von Eichel-Streiber, C., Turner, J. R., Verkade, P., Madara, J. L., & Parkos, C. A. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1329-1336.2001 · Cited by 350
Fasano, A., Fiorentini, C., Donelli, G., Uzzau, S., Kaper, J. B., Margaretten, K., Ding, X., Guandalini, S., Comstock, L., & Goldblum, S. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118114 · Cited by 342
Lindmark, T., Kimura, Y., & Artursson, P. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37216-7 · Cited by 333
Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M., & Muranishi, S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018968611962 · Cited by 320
McClements, D. J., Li, F., & Xiao, H. (2015) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032814-014043 · Cited by 315
(C) Means to enhance penetration
Scott Swenson, E., & Curatolo, W. J. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90015-i · Cited by 314
Blair, S. A., Kane, S. V., Clayburgh, D. R., & Turner, J. R. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700373 · Cited by 299
Aguirre, T. A. S., Teijeiro-Osorio, D., Rosa, M., Coulter, I. S., Alonso, M. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.004 · Cited by 299
Self-citationIncreased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig, R., Andus, T., Aschenbrenner, E., Falk, W., Schölmerich, J., & Gross, V (1996) · Gut · doi:10.1136/gut.38.2.216 · Cited by 291
Enzymatic barriers for GI peptide and protein delivery.
Woodley, J. F. (1994) · PubMed · Cited by 291
Nerurkar, M. M., Burton, P. S., & Borchardt, R. T. (1996) · Pharmaceutical Research · doi:10.1023/a:1016033702220 · Cited by 287
Youakim, A., & Ahdieh, M. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.5.g1279 · Cited by 286
Lueßen, H. L., de Leeuw, B. J., Langemeÿer, M. W. E., de Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1996) · Pharmaceutical Research · doi:10.1023/a:1016488623022 · Cited by 273
The Binding of Detergents to Proteins
Nelson, C. A. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62118-0 · Cited by 269
Fasano, A., & Uzzau, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119271 · Cited by 266
Maher, S., & McClean, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.012 · Cited by 264
Self-citationEthanol modulation of intestinal epithelial tight junction barrier
Ma, T. Y., Nguyen, D., Bui, V., Nguyen, H., & Hoa, N. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.4.g965 · Cited by 261
van der Merwe, S. M., Verhoef, J. C., Verheijden, J. H. M., Kotzé, A. F., & Junginger, H. E. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.023 · Cited by 260
Wound healing of intestinal epithelial cells
Iizuka, M. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i17.2161 · Cited by 259
A classification of biologic lipids based upon their interaction in aqueous systems
Small, D. M. (1968) · Journal of the American Oil Chemists' Society · doi:10.1007/bf02915334 · Cited by 257
Chitosan and its derivatives: potential excipients for peroral peptide delivery systems
Bernkop-Schnürch, A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00365-8 · Cited by 250
Papini, E., Satin, B., Norais, N., de Bernard, M., Telford, J. L., Rappuoli, R., & Montecucco, C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2764 · Cited by 247
Alteration of intestinal tight junction structure and permeability by cytoskeletal contraction
Madara, J. L., Moore, R., & Carlson, S. (1987) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1987.253.6.c854 · Cited by 247
Kotzé, A. R., Lueβen, H. L., de Leeuw, B. J., de Boer, B. G., Verhoef, J. C., & Junginger, H. E. (1997) · Pharmaceutical Research · doi:10.1023/a:1012106907708 · Cited by 245
Wang, J., Yadav, V., Smart, A. L., Tajiri, S., & Basit, A. W. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500809f · Cited by 245
Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems
Bernkop-Schnürch, A. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.05.001 · Cited by 244
Adams, R. B., Planchon, S. M., & Roche, J. K. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.6.2356 · Cited by 240
Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats
Barichello, J. M., Morishita, M., Takayama, K., & Nagai, T. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00119-2 · Cited by 235
Nauck, M. A., Petrie, J. R., Sesti, G., Mannucci, E., Courrèges, J.-P., Lindegaard, M. L., Jensen, C. B., & Atkin, S. L. (2016) · Diabetes Care · doi:10.2337/dc15-0165 · Cited by 233
Sha, X., Yan, G., Wu, Y., Li, J., & Fang, X. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.01.001 · Cited by 231
Ranaldi, G., Marigliano, I., Vespignani, I., Perozzi, G., & Sambuy, Y. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(01)00208-x · Cited by 230
Enhancing paracellular permeability by modulating epithelial tight junctions
Ward, P. D., Tippin, T. K., & Thakker, D. R. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00302-3 · Cited by 227
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic
Maher, S., Leonard, T. W., Jacobsen, J., & Brayden, D. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.006 · Cited by 227
Self-citationThe drug efflux–metabolism alliance: biochemical aspects
Benet, L. Z., & Cummins, C. L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00178-8 · Cited by 226
Kotzé, A. F., Lueßen, H. L., de Leeuw, B. J., de Boer, (. G., Coos Verhoef, J., & Junginger, H. E. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00154-5 · Cited by 226
Anderberg, E. K., Lindmark, T., & Artursson, P. (1993) · Pharmaceutical Research · doi:10.1023/a:1018909210879 · Cited by 221
Salzman, A. L., Menconi, M. J., Unno, N., Ezzell, R. M., Casey, D. M., Gonzalez, P. K., & Fink, M. P. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.268.2.g361 · Cited by 220
Anderberg, E. K., Nyström, C., & Artursson, P. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810908 · Cited by 214
An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop
Lehr, C.-M., Poelma, F. G. J., Junginger, H. E., & Tukker, J. J. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90287-x · Cited by 212
New horizons — alternative routes for insulin therapy
Owens, D. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd836 · Cited by 209
Knipp, G. T., Ho, N. F. H., Barsuhn, C. L., & Borchardt, R. T. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9700309 · Cited by 208
Commercial challenges of protein drug delivery
Brown, L. R. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.29 · Cited by 208
INTERLEUKIN-8 AS AN AUTOCRINE GROWTH FACTOR FOR HUMAN COLON CARCINOMA CELLS IN VITRO
Brew, R., Erikson, J. S., West, D. C., Kinsella, A. R., Slavin, J., & Christmas, S. E. (2000) · Cytokine · doi:10.1006/cyto.1999.0518 · Cited by 207
Zonula Occludens Toxin Structure-Function Analysis
Di Pierro, M., Lu, R., Uzzau, S., Wang, W., Margaretten, K., Pazzani, C., Maimone, F., & Fasano, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009674200 · Cited by 206
Structural insight into tight junction disassembly by Clostridium perfringens enterotoxin
Saitoh, Y., Suzuki, H., Tani, K., Nishikawa, K., Irie, K., Ogura, Y., Tamura, A., Tsukita, S., & Fujiyoshi, Y. (2015) · Science · doi:10.1126/science.1261833 · Cited by 205
Surfactants in membrane solubilisation
Jones, M. N. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00345-7 · Cited by 203
Kelly, C. P., Green, P. H. R., Murray, J. A., DiMarino, A., Colatrella, A., Leffler, D. A., Alexander, T., Arsenescu, R., Leon, F., Jiang, J. G., et al. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12147 · Cited by 202
Lindmark, T., Nikkilä, T., & Artursson, P. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12150-2 · Cited by 200
Structural requirements for intestinal absorption of peptide drugs
Pauletti, G. M., Gangwar, S., Knipp, G. T., Nerurkar, M. M., Okumu, F. W., Tamura, K., Siahaan, T. J., & Borchardt, R. T. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01352-1 · Cited by 198
Liquid filled nanoparticles as a drug delivery tool for protein therapeutics
Venkatesan, N., Yoshimitsu, J., Ιtο, Y., Shibata, N., & Takada, K. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.012 · Cited by 198
Intestinal Epithelium in Inflammatory Bowel Disease
Coskun, M. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00024 · Cited by 197
Diffusion of Drugs in Native and Purified Gastrointestinal Mucus
Larhed, A. W., Artursson, P., Gråsjö, J., & Björk, E. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960503w · Cited by 194
(2002) · International Journal of Toxicology · doi:10.1080/10915810290096522 · Cited by 192
Constantinides, P. P., & Scalart, J.-P. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00248-2 · Cited by 188
(2006) · CRC Press eBooks · doi:10.1201/9781420004816 · Cited by 187
Leffler, D. A., Kelly, C. P., Abdallah, H. Z., Colatrella, A. M., Harris, L. A., Leon, F., Arterburn, L. A., Paterson, B. M., Lan, Z. H., & Murray, J. A. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.211 · Cited by 187
Artursson, P., & Magnusson, C. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790710 · Cited by 183
Structure and cohesive properties of sphingomyelin/cholesterol bilayers
McIntosh, T. J., Simon, S. A., Needham, D., & Huang, C. H. (1992) · Biochemistry · doi:10.1021/bi00122a017 · Cited by 180
Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats
Krauland, A. H., Guggi, D., & Bernkop-Schnürch, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.017 · Cited by 176
Sphingomyelins in bilayers and biological membranes
Barenholz, Y., & Thompson, T. E. (1980) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(80)90006-4 · Cited by 174
‘Putting the squeeze’ on the tight junction: understanding cytoskeletal regulation
Turner, J. R. (2000) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0180 · Cited by 173
Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
Melmed, S., Popovic, V., Bidlingmaier, M., Mercado, M., van der Lely, A. J., Biermasz, N., Bolanowski, M., Coculescu, M., Schopohl, J., Racz, K., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4113 · Cited by 173
Oral biodrug delivery using cell-penetrating peptide
Khafagy, E.-S., & Morishita, M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.014 · Cited by 173
The challenge of proteolytic enzymes in intestinal peptide delivery
Langguth, P., Bohner, V., Heizmann, J., Merkle, H. P., Wolffram, S., Amidon, G. L., & Yamashita, S. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01586-6 · Cited by 170
Absorption-Enhancing Mechanism of EDTA, Caprate, and Decanoylcarnitine in Caco-2 Cells
Tomita, M., Hayashi, M., & Awazu, S. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9504604 · Cited by 169
Madden, K. B., Whitman, L., Sullivan, C., Gause, W. C., Urban, J. F., Katona, I. M., Finkelman, F. D., & Shea-Donohue, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4417 · Cited by 167
Recent Developments in Protein and Peptide Parenteral Delivery Approaches
Patel, A., Cholkar, K., & Mitra, A. K. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.5 · Cited by 166
Rapid barrier restitution in an in vitro model of intestinal epithelial injury.
Moore, R., Carlson, S., & Jl, M. (1989) · PubMed · Cited by 166
A novel approach using functional peptides for efficient intestinal absorption of insulin
Morishita, M., Kamei, N., Ehara, J., Isowa, K., & Takayama, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.022 · Cited by 165
Krug, S. M., Amasheh, M., Dittmann, I., Christoffel, I., Fromm, M., & Amasheh, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.051 · Cited by 164
Anderberg, E. K., & Artursson, P. (1993) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600820412 · Cited by 164
Characterization of chitosan acetate as a binder for sustained release tablets
Nunthanid, J., Laungtana-anan, M., Sriamornsak, P., Limmatvapirat, S., Puttipipatkhachorn, S., Lim, L. Y., & Khor, E. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.008 · Cited by 163
Tuvia, S., Atsmon, J., Teichman, S. L., Katz, S., Salama, P., Pelled, D., Landau, I., Karmeli, I., Bidlingmaier, M., Strasburger, C. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1179 · Cited by 160
Govers, M., Termont, D., Lapré, J. A., Kleibeuker, J., Vonk, R., & van der Meer, R. (1996) · PubMed · Cited by 152
Functional coupling of tight junctions and microfilaments in T84 monolayers
Madara, J., Stafford, J., Barenberg, D., & Carlson, S. (1988) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1988.254.3.g416 · Cited by 152
Nielsen, E. J. B., Yoshida, S., Kamei, N., Iwamae, R., Khafagy, E., Olsen, J., Rahbek, U. L., Pedersen, B. L., Takayama, K., & Takeda‐Morishita, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.022 · Cited by 151
Binkley, N., Bolognese, M., Sidorowicz-Bialynicka, A., Vally, T., Trout, R., Miller, C., Buben, C. E., Gilligan, J. P., Krause, D. S., & for the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1602 · Cited by 149 · cited 4×
“In 2009, Peptelligence TM was licensed to Tarsa Therapeutics (USA) for clinical development of an oral formulation of recombinant sCT, which successfully achieved its primary endpoint in a phase III trial of Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) [192] (discussed by Aguirre et al in this Issue [4]).”
BackgroundInfluentialCeponis, P. J. M., Botelho, F. M., Richards, C. D., & McKay, D. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003516200 · Cited by 149
Sakai, M., Imai, T., Ohtake, H., Azuma, H., & Otagiri, M. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960529n · Cited by 149
Nava, P., López, S., Arias, C. F., Islas, S., & González‐Mariscal, L. (2004) · Journal of Cell Science · doi:10.1242/jcs.01425 · Cited by 149
Sonaje, K., Lin, K., Tseng, M. T., Wey, S., Su, F.-Y., Chuang, E., Hsu, C.-W., Chen, C.-T., & Sung, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.086 · Cited by 147
The Use of BDDCS in Classifying the Permeability of Marketed Drugs
Benet, L. Z., Amidon, G. L., Barends, D. M., Lennernäs, H., Polli, J. E., Shah, V. P., Stavchansky, S. A., & Yu, L. X. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9523-x · Cited by 147
Ma, T. Y., Tran, D., Hoa, N. T., Nguyen, D., Merryfield, M., & Tarnawski, A. S. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20001015)51:2<156::aid-jemt7>3.0.co;2-j · Cited by 146
Thanou, M., Florea, B. I., Langemeÿer, M. W. E., et al. (2000) · Pharmaceutical Research · doi:10.1023/a:1007558206506 · Cited by 145
Karsdal, M. A., Byrjalsen, I., Alexandersen, P., Bihlet, A., Andersen, J. R., Riis, B. J., Bay-Jensen, A. C., & Christiansen, C. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.12.019 · Cited by 143
A Novel Strategy for the Enhancement of Drug Absorption Using a Claudin Modulator
Kondoh, M., Masuyama, A., Takahashi, A., Asano, N., Mizuguchi, H., Koizumi, N., Fujii, M., Hayakawa, T., Horiguchi, Y., & Watanbe, Y. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.008375 · Cited by 143
Uchiyama, T., Sugiyama, T., Quan, Y., Kotani, A., Okada, N., Fujita, T., Muranishi, S., & Yamamoto, A. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991776976 · Cited by 142
Tuvia, S., Pelled, D., Marom, K., Salama, P., Levin-Arama, M., Karmeli, I., Idelson, G. H., Landau, I., & Mamluk, R. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1303-9 · Cited by 142
Ochratoxin A increases permeability through tight junctions by removal of specific claudin isoforms
McLaughlin, J. T., Padfield, P. J., Burt, J. P. H., & O’Neill, C. A. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00007.2004 · Cited by 141
MORISHITA, M., Morishita, I., TAKAYAMA, K., Machida, Y., & NAGAI, T. (1993) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.16.68 · Cited by 141
Sharma, G., Wilson, K., van der Walle, C. F., Sattar, N. A., Petrie, J. R., & Kumar, M. N. V. R. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.07.002 · Cited by 140
Pavlidis, P., Powell, N., Vincent, R. P., Ehrlich, S. D., Bjarnason, I., & Hayee, B. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13333 · Cited by 138
Effects of Some Non-ionic Surfactants on Transepithelial Permeability in Caco-2 Cells
Dimitrijević, D., Shaw, A. J., & Florence, A. T. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001773805 · Cited by 137
Kotzé, A. F., de Leeuw, B. J., Lueßen, H. L., Boer, A. G. D., Verhoef, J. C., & Junginger, H. E. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00287-1 · Cited by 136
Prajapati, H. N., Dalrymple, D. M., & Serajuddin, A. T. M. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0541-3 · Cited by 136
Manicourt, D., Azria, M., Mindeholm, L., Thonar, E. J. ‐., & Devogelaer, J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22075 · Cited by 135
Leonard, T. W., Lynch, J. J., McKenna, M. J., & Brayden, D. J. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.5.685 · Cited by 135
Self-citationClasses and Prediction of Cell-Penetrating Peptides
Lindgren, M., & Langel, Ü. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-919-2_1 · Cited by 133
Enhancement of Colonic Drug Absorption by the Transcellular Permeation Route
Tomita, M., Hayashi, M., Horie, T., Ishizawa, T., & Awazu, S. (1988) · Pharmaceutical Research · doi:10.1023/a:1015992819290 · Cited by 133
Mucoadhesive systems in oral drug delivery
Bernkop‐Schnürch, A. (2005) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2005.05.001 · Cited by 133
PKC-dependent regulation of transepithelial resistance: roles of MLC and MLC kinase
Turner, J. R., Angle, J. M., Black, E. D., Joyal, J. L., Sacks, D. B., & Madara, J. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.3.c554 · Cited by 132
Lorenz, M., Evers, A., & Wagner, M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.022 · Cited by 130
Oral Delivery of Anticoagulant Doses of Heparin
Baughman, R., Kapoor, S. C., Agarwal, R., Kisicki, J. C., Catella-Lawson, F., & FitzGerald, G. A. (1998) · Circulation · doi:10.1161/01.cir.98.16.1610 · Cited by 129
Lichtenberger, L. M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00576-1 · Cited by 129
Oral Insulin: The Rationale for This Approach and Current Developments
Arbit, E., & Kidron, M. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300322 · Cited by 128
Passage of cell-penetrating peptides across a human epithelial cell layer in vitro
Lindgren, M., Hällbrink, M., Elmquist, A., & Langel, Ü. (2004) · Biochemical Journal · doi:10.1042/bj20030760 · Cited by 127
Oral Delivery of Antisense Oligonucleotides in Man
Tillman, L., Geary, R. S., & Hardee, G. E. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21084 · Cited by 127
Role for IL-4 in macromolecular transport across human intestinal epithelium
Berin, M. C., Yang, P., Ciok, L., Waserman, S., & Perdue, M. H. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.5.c1046 · Cited by 127
Claudin-related intestinal diseases
Barmeyer, C., Schulzke, J. D., & Fromm, M. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.05.006 · Cited by 124
Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency
Liang, J. F., & Yang, V. C.-M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.142 · Cited by 124
A Key Claudin Extracellular Loop Domain is Critical for Epithelial Barrier Integrity
Mrsny, R. J., Brown, G. T., Gerner-Smidt, K., Buret, A. G., Meddings, J. B., Quan, C. L., Koval, M. H., & Nusrat, A. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070698 · Cited by 124
Self-citationFood, physiology and drug delivery
Varum, F., Hatton, G. B., & Basit, A. W. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.034 · Cited by 121
Absorption of protein via the intestinal wall
Ziv, E., Lior, O., & Kidron, M. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90411-4 · Cited by 120
Prasad, Y. V. R., Puthli, S. P., Eaimtrakarn, S., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00544-6 · Cited by 118
Round, A. N., Rigby, N. M., la Torre, A. G.-D., Macierzanka, A., Mills, E. N. C., & Mackie, A. R. (2012) · Biomacromolecules · doi:10.1021/bm301024x · Cited by 117
Lin, Y., Shen, Q., Katsumi, H., Okada, N., Fujita, T., Jiang, X., & Yamamoto, A. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1301 · Cited by 114
Dennis, E. A. (1974) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(74)90305-1 · Cited by 114
A New Principle for Tight Junction Modulation Based on Occludin Peptides
Tavelin, S., Hashimoto, K., Malkinson, J. P., Lazorova, L., Tóth, I., & Artursson, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1530 · Cited by 114
Targeted enteral delivery of insulin to rats
Touítou, E., & Rubinstein, A. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90069-4 · Cited by 112
Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins
Fasano, A., & Nataro, J. P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.045 · Cited by 111
Bagger, Y. Z., Tankó, L. B., Alexandersen, P., Karsdal, M. A., Olson, M., Mindeholm, L., Azria, M., & Christiansen, C. (2005) · Bone · doi:10.1016/j.bone.2005.04.032 · Cited by 109
Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase
Ma, T. Y., Hoa, N. T., Tran, D., Bui, V., Pedram, A., Mills, S., & Merryfield, M. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.5.g875 · Cited by 109
Clinical Evidence for the Earlier Initiation of Insulin Therapy in Type 2 Diabetes
Owens, D. R. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0081 · Cited by 108
Oral delivery of salmon calcitonin
Lee, Y.-H., & Sinko, P. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00063-6 · Cited by 108
Lo, Y., & Huang, J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00377-9 · Cited by 108
Micellization of bile salts in aqueous medium: A fluorescence study
Subuddhi, U., & Mishra, A. K. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.01.009 · Cited by 106
Two-Path Impedance Spectroscopy for Measuring Paracellular and Transcellular Epithelial Resistance
Krug, S. M., Fromm, M., & Günzel, D. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.08.003 · Cited by 106
Gullikson, G. W., Cline, W. S., Lorenzsonn, V., Benz, L., Olsen, W. A., & Bass, P. (1977) · Gastroenterology · doi:10.1016/s0016-5085(19)32131-6 · Cited by 106
Lindmark, T., Söderholm, J. D., Olaison, G., et al. (1997) · Pharmaceutical Research · doi:10.1023/a:1012112219578 · Cited by 105
Rodriguez, P., Heyman, M., Candalh, C., Blaton, M. A., & Bouchaud, C. (1995) · Cytokine · doi:10.1006/cyto.1995.0060 · Cited by 105
Sandri, G., Rossi, S., Ferrari, F., Bonferoni, M. C., Zerrouk, N., & Caramella, C. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044085 · Cited by 105
Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion
Kvietys, P. R., Specian, R. D., Grisham, M. B., & Tso, P. (1991) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1991.261.3.g384 · Cited by 105
How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?
Malhaire, H., Gimel, J.-C., Roger, E., Benoît, J., & Lagarce, F. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.011 · Cited by 105
Matsumura, T., Jin, Y., Kabumoto, Y., Takegahara, Y., Oguma, K., Lencer, W. I., & Fujinaga, Y. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01048.x · Cited by 104
Thanou, M., Verhoef, J. C., Romeijn, S. G., Nagelkerke, J. F., Merkus, F. W. H. M., & Junginger, H. E. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00126-x · Cited by 104
Physicochemical and Formulation Developability Assessment for Therapeutic Peptide Delivery—A Primer
Bak, A., Leung, D., Barrett, S. E., Forster, S. P., Minnihan, E. C., Leithead, A., Cunningham, J., Toussaint, N., & Crocker, L. S. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9688-2 · Cited by 103
Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin
Cui, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26450 · Cited by 103
The potential of chitosan for the oral administration of peptides
Prego, C., Torres, D., & Alonso, M. J. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.5.843 · Cited by 102
Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells.
Tomita, M., Hayashi, M., & AWAZU, S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24472-x · Cited by 102
Rubinstein, A., Tirosh, B., Baluom, M., Nassar, T., David, A., Radai, R., Gliko-Kabir, I., & Friedman, M. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01582-9 · Cited by 100
Karsdal, M. A., Byrjalsen, I., Henriksen, K., Riis, B. J., Lau, E. M. C., Arnold, M., & Christiansen, C. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.08.004 · Cited by 98
Oral Delivery of Insulin with the eligen(®) Technology: Mechanistic Studies
Malkov, D., Angelo, R., Wang, H., et al. (2005) · Current Drug Delivery · doi:10.2174/1567201053586001 · Cited by 98
On the Interaction of Clostridium perfringens Enterotoxin with Claudins
Veshnyakova, A., Protze, J., Rossa, J., Blasig, I. E., Krause, G., & Piontek, J. (2010) · Toxins · doi:10.3390/toxins2061336 · Cited by 98
An enteric-coated dry emulsion formulation for oral insulin delivery
Toorisaka, E., Hashida, M., Kamiya, N., Ono, H., Kokazu, Y., & Goto, M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.022 · Cited by 98
Liu, D.-Z., LeCluyse, E. L., & Thakker, D. R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js990094e · Cited by 96
Formulation and characterization of an oily-based system for oral delivery of insulin
Elsayed, A., Al-Remawi, M. M., Qinna, N. A., Farouk, A., & Badwan, A. A. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.004 · Cited by 95
Tankó, L. B., Bagger, Y. Z., Alexandersen, P., Devogelaer, J.-P., Reginster, J., Chick, R., Olson, M. S., Benmammar, H., Mindeholm, L., Azria, M., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040715 · Cited by 94
Khafagy, E., Morishita, M., Kamei, N., Eda, Y., Ikeno, Y., & Takayama, K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.022 · Cited by 94
Steinert, R. E., Poller, B., Castelli, M., Drewe, J., & Beglinger, C. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29663 · Cited by 94
Cited by
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Advances in oral peptide therapeutics
Drucker, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0053-0 · Cited by 646
Transcellular Stomach Absorption of a Derivatized Glucagon-Like Peptide-1 Receptor Agonist
Buckley, S. T., Bækdal, T. A., Vegge, A., Maarbjerg, S. J., Pyke, C., Ahnfelt-Rønne, J., Madsen, K. G., Schéele, S. G., Alanentalo, T., Kirk, R. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar7047 · Cited by 553
Xu, Q., Hong, H., Wu, J., & Yan, X. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.02.050 · Cited by 368
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
Zhu, Q., Chen, Z., Paul, P. K., Lu, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 353
Metadata
- Authors
- Maher, S., Mrsny, R. J., & Brayden, D. J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 106
- Issue
- Pt B
- Pages
- 277-319
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2433570839
- Cited by
- 381
- References
- 396
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.